Ob/Gyn Articles

Ob/Gyn

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Anonychuk AM et al. – In the context of current screening patterns, vaccination of 12–year old Canadian females with an ASO4–ajuvanted cervical cancer vaccine is estimated to significantly reduce cervical cancer and mortality, and is a cost–effective option. However, the economic attractiveness of vaccination is impacted by the vaccine's duration of protection and the discount rate used in the analysis.


Related Articles

Screening for cervical cancer among Israeli lesbian women
International Nursing Review, 11/17/09    Relevance Score: 79%

Beliefs about the causes of cervical cancer in Botswana: implications for nursing
International Nursing Review, 11/16/09    Relevance Score: 79%

State-Level Differences in Breast and Cervical Cancer Screening by Disability Status: United States, 2008
Women's Health Issues, 11/04/09    Relevance Score: 79%

Effectiveness of cervical cancer screening at different ages
Women's Health, 10/30/09    Relevance Score: 79%

Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States
Annals of Internal Medicine, 10/21/09    Relevance Score: 78%

Today in Gynecologic Oncology...keeping you current

Screening for breast cancer post reduction mammoplasty
Clinical Radiology, 02/09/10

Menstrual blood human papillomavirus DNA detection in patients with cervical intraepithelial neoplasia and condyloma acuminatum
Journal of Clinical Microbiology, 02/09/10

Intraparenchymal metastases to the spleen from ovarian cancer: a case report
Journal of Medical Case Reports, 02/09/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address